[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

June 2019 - July 1883

Decade

Year

Issue

April 23/30, 2019, Vol 321, No. 16, Pages 1547-1642

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2019;321(16):1547-1549. doi:10.1001/jama.2018.15300
Original Investigation

Effect of Addition of an Intimate Partner Violence Intervention to a Nurse Home Visitation Program on Maternal Quality of Life: A Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA. 2019;321(16):1576-1585. doi:10.1001/jama.2019.3211

This cluster randomized trial compares the effect of a nurse home visitation program augmented by an intimate partner violence (IPV) intervention vs nurse home visitation alone on quality of life 24 months after delivery among first-time mothers experiencing social and economic disadvantage.

Trends in Sedentary Behavior Among the US Population, 2001-2016

Abstract Full Text
has active quiz
JAMA. 2019;321(16):1587-1597. doi:10.1001/jama.2019.3636

This national survey study uses National Health and Nutrition Examination Survey (NHANES) data to describe trends in sedentary behaviors of the adolescent and adult US population, including watching television or videos for 2 or more hours per day, computer use 1 or more hour per day, and total sitting time.

Association of State Medicaid Expansion Status With Low Birth Weight and Preterm Birth

Abstract Full Text
has active quiz
JAMA. 2019;321(16):1598-1609. doi:10.1001/jama.2019.3678

This study uses national health statistics data to evaluate associations between state Medicaid expansion in 2014-2016 and changes in rates of low birth weight and preterm birth, both overall and by race/ethnicity.

Research Letter

Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018

Abstract Full Text
JAMA. 2019;321(16):1627-1629. doi:10.1001/jama.2019.2990

This study uses Medicaid drug utilization data to describe reimbursement and market share of long-acting insulins before and after approval of new insulin products and to estimate savings associated with a “biosimilar” for insulin glargine approved in 2015.

US State Regulation of Decisions for Pregnant Women Without Decisional Capacity

Abstract Full Text
JAMA. 2019;321(16):1629-1631. doi:10.1001/jama.2019.2587

This study characterizes the prevalence and content of US state statutes governing treatment decisions for decisionally incapacitated pregnant women.

Special Communication

Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement

Abstract Full Text
free access
JAMA. 2019;321(16):1610-1620. doi:10.1001/jama.2019.3087

This extension of the CONSORT 2010 Statement, a guideline and checklist for reporting parallel group randomized trials, provides updates for the reporting of multi-arm trials to assist evaluations of rigor and reproducibility and enhance understanding of the methodology of trials with more than 2 comparison arms.

Viewpoint

Health Policy

The States as Important Laboratories for Federal Prescription Drug Cost-Containment Efforts

Abstract Full Text
JAMA. 2019;321(16):1561-1562. doi:10.1001/jama.2019.2189

This Viewpoint proposes ways states can control the costs of expensive drugs produced by single manufacturers, including importation from other countries, international benchmark pricing, and statewide upper payment limits.

Health Policy

Prescription Drugs—List Price, Net Price, and the Rebate Caught in the Middle

Abstract Full Text
JAMA. 2019;321(16):1563-1564. doi:10.1001/jama.2019.2445

In this Viewpoint, Peter Bach and colleague Stacie Dusetzina question the assumption underlying a 2019 proposed federal rule change to eliminate drug manufacturer rebates to pharmacy benefit managers (PBMs) as a way to decrease prescription drug prices, and they propose more extensive restructuring, including a cap on out-of-pocket spending for Medicare Part D beneficiaries, to better control drug costs and save patients money.

Health Policy

Canada’s Amendment to Patented Drug Price Regulation: A Prescription for Global Drug Cost Control?

Abstract Full Text
JAMA. 2019;321(16):1565-1566. doi:10.1001/jama.2019.2280

This Viewpoint reviews proposed changes to regulations governing Canada’s Patented Medicine Process Review Board, a group mandated by Canada’s government to ensure manufacturers do not charge excessive drug prices, including use of cost-utility analyses to define excessive pricing, revision of reference country comparisons, and reducing regulatory burdens for generic drugs.

Health Policy

Novel Therapies for an Aging Population: Grappling With Price, Value, and Affordability

Abstract Full Text
JAMA. 2019;321(16):1567-1568. doi:10.1001/jama.2019.2633

This Viewpoint discusses the costs of emerging therapies for conditions prevalent in the US Baby Boomer population now entering old age and proposes principles to ensure the value and accessibility of new expensive drugs including cost-effectiveness (CE) assessments, price-benefit alignment, and incorporation of CE data into clinical practice guidelines.

A Piece of My Mind

The Right to Grieve

Abstract Full Text
JAMA. 2019;321(16):1569-1570. doi:10.1001/jama.2019.4265

In this narrative medicine essay a neurointensivist discusses her evolving understanding of her personal and professional responses to patient deaths, the pressures physicians face not to grieve, and the importance of attending patients’ funerals for bringing closure to relationships with patient families and easing feelings of guilt, sadness, isolation, and denial.

Editorial

Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation

Abstract Full Text
has audio
JAMA. 2019;321(16):1571-1573. doi:10.1001/jama.2019.3846

Statutory Restrictions on Advance Care Planning and Pregnancy

Abstract Full Text
JAMA. 2019;321(16):1574-1575. doi:10.1001/jama.2019.2588
JAMA Insights

Clinical Update

Management of Small Kidney Tumors in 2019

Abstract Full Text
JAMA. 2019;321(16):1622-1623. doi:10.1001/jama.2019.1672

This JAMA Insights Clinical Update reviews the diagnosis and treatment options for small kidney tumors including active surveillance, biopsy, radical nephrectomy, and nephron-sparing treatments (partial nephrectomy and percutaneous ablation).

JAMA Clinical Challenge

A Man With Headache, Fever, and Neck Stiffness

Abstract Full Text
free access has active quiz
JAMA. 2019;321(16):1624-1625. doi:10.1001/jama.2019.1772

A 53-year-old man with a history of pseudogout and receiving immunosuppressives after renal transplant had 2 weeks of stiff neck, headache, and fevers and 3 days of right knee pain and swelling with nuchal rigidity, a positive Kernig sign, no focal neurologic deficits, and a right knee effusion on examination. Blood and CSF cultures were negative, WBC count was high normal, and cervical MRI showed degenerative changes with periodontoid calcifications and reactive marrow. What is the diagnosis and what would you do next?

Editor's Note

Addition of an Intimate Partner Violence Intervention to a Nurse Home Visitation Program

Abstract Full Text
free access
JAMA. 2019;321(16):1586. doi:10.1001/jama.2019.3712

Medicaid Expansion and Birth Outcomes

Abstract Full Text
free access
JAMA. 2019;321(16):1609. doi:10.1001/jama.2019.3824

A Tribute to Douglas G. Altman, DSc

Abstract Full Text
free access
JAMA. 2019;321(16):1621. doi:10.1001/jama.2019.3830
Medical News & Perspectives

Unpacking a Recent Study Linking Diet Soda With Stroke Risks

Abstract Full Text
has audio
JAMA. 2019;321(16):1554-1555. doi:10.1001/jama.2019.2123

This Medical News article is an interview with Yasmin Mossavar-Rahmani, PhD, RD, who studied the association of artificially sweetened beverages with cardiovascular disease and mortality in women.

Quick Uptakes

Chemicals in Consumer Products Associated With Early Puberty

Abstract Full Text
has audio
JAMA. 2019;321(16):1556. doi:10.1001/jama.2019.1111

This Medical News article discusses prenatal and peripubertal exposures to phthalates, parabens, and phenols and associations with puberty timing.

News From the Centers for Disease Control and Prevention

Trends in Blood Infection Rates

Abstract Full Text
JAMA. 2019;321(16):1559. doi:10.1001/jama.2019.3818

Traumatic Brain Injuries Among Youth

Abstract Full Text
JAMA. 2019;321(16):1559. doi:10.1001/jama.2019.3877
Clinical Trials Update

Rapid Blood Pressure Reduction Safe for Ischemic Stroke

Abstract Full Text
JAMA. 2019;321(16):1558. doi:10.1001/jama.2019.3797

Caring Text Messages for Preventing Suicides

Abstract Full Text
JAMA. 2019;321(16):1558. doi:10.1001/jama.2019.4592

Acupuncture May Reduce Menopausal Symptoms

Abstract Full Text
JAMA. 2019;321(16):1558. doi:10.1001/jama.2019.4593

Flexible Duty Hours, Sleep, and Patient Outcomes

Abstract Full Text
JAMA. 2019;321(16):1558. doi:10.1001/jama.2019.4594
Health Agencies Update

HHS Funds Development of Vaccine Against Marburg Virus

Abstract Full Text
JAMA. 2019;321(16):1557. doi:10.1001/jama.2019.4035

Screening Preteens in the Emergency Department for Suicide Risk

Abstract Full Text
JAMA. 2019;321(16):1557. doi:10.1001/jama.2019.4588

Free App to Help Patients Ask Appropriate Questions

Abstract Full Text
JAMA. 2019;321(16):1557. doi:10.1001/jama.2019.4590
Poetry and Medicine

The Suit

Abstract Full Text
JAMA. 2019;321(16):1637. doi:10.1001/jama.2019.1494
JAMA Revisited

Medicolegal: Conditions Warranting Requirement of Vaccination

Abstract Full Text
JAMA. 2019;321(16):1638. doi:10.1001/jama.2018.15308
JAMA Patient Page

Croup

Abstract Full Text
free access
JAMA. 2019;321(16):1642. doi:10.1001/jama.2019.2013

This JAMA Patient Page describes the symptoms, diagnosis, and treatment of croup in children.

Comment & Response

Post Hoc Bayesian Analyses

Abstract Full Text
JAMA. 2019;321(16):1631-1632. doi:10.1001/jama.2019.1198

Post Hoc Bayesian Analyses

Abstract Full Text
JAMA. 2019;321(16):1632. doi:10.1001/jama.2019.1194

Post Hoc Bayesian Analyses—Reply

Abstract Full Text
JAMA. 2019;321(16):1632-1633. doi:10.1001/jama.2019.1202

Patient-Physician Relationship in the Age of Expanded Access to Information

Abstract Full Text
JAMA. 2019;321(16):1633. doi:10.1001/jama.2019.1066

Patient-Physician Relationship in the Age of Expanded Access to Information—Reply

Abstract Full Text
JAMA. 2019;321(16):1633-1634. doi:10.1001/jama.2019.1073

Additional Approaches to Treatment of Depression

Abstract Full Text
JAMA. 2019;321(16):1634-1635. doi:10.1001/jama.2019.2052

Additional Approaches to Treatment of Depression

Abstract Full Text
JAMA. 2019;321(16):1635. doi:10.1001/jama.2019.2068

Additional Approaches to Treatment of Depression—Reply

Abstract Full Text
JAMA. 2019;321(16):1635-1636. doi:10.1001/jama.2019.2092
Correction

Numerical Errors and Addition of a Sentence

Abstract Full Text
free access
JAMA. 2019;321(16):1636. doi:10.1001/jama.2019.3497

Error in the Introduction

Abstract Full Text
free access
JAMA. 2019;321(16):1636. doi:10.1001/jama.2019.3897

Data Error

Abstract Full Text
free access
JAMA. 2019;321(16):1636. doi:10.1001/jama.2019.4254
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2019;321(16):1551-1552. doi:10.1001/jama.2018.15301
×